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Abstract
Carbapenemase-producing Enterobacteriaceae isolates are being increasingly reported, particularly from countries surrounding the
Mediterranean area. We aimed to quantify the prevalence of carbapenemase- and extended-spectrum b-lactamase (ESBL)-producing
Enterobacteriaceae in rectal swabs from hospitalized patients in a University hospital in Morocco, and to compare the performance of three
screening media: ChromID ESBL (bioMerieux), Brilliance CRE (OXOID, Thermoﬁsher) and SUPERCARBA (home made). Genetic detection
and plasmid analysis were performed by PCR and sequencing. Strain comparison was performed by multi-locus sequence typing and the
Diversilab technique (bioMerieux). The prevalence of multidrug-resistant Enterobacteriaceae was high, with 33 ESBL producers (42.85%,
mainly CTX-M-15) and 10 OXA-48 producers (13%), corresponding to two major clones of K. pneumoniae (70%) and a clone of Enterobacter
cloacae (30%). The three screeningmedia showed the same sensitivity for detection of carbapenemase-producing Enterobacteriaceae, whereas
the SUPERCARBA medium was more speciﬁc than the two other media. The average faecal carriage of ESBL or carbapenemase-producing
Enterobacteriaceae varied from 1 9 102 to >1 9 108 CFU/g of stools. This study shows a high prevalence of multidrug-resistant
Enterobacteriaceae, and particularly of OXA-48 producers. The new carbapenem-containing medium, SUPERCARBA, was as sensitive as
Brilliance CRE and ChromID ESBL, and more speciﬁc for the detection of Enterobacteriaceae expressing those carbapenemases.
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Introduction
Carbapenemase-producing Enterobacteriaceae (CPE) isolates
have been increasingly reported worldwide, and among them
OXA-48 is mostly identiﬁed from countries surrounding the
Mediterranean area [1–3].
Faecal carriage of CPE isolates has been rarely investigated,
compared with carriage of extended-spectrum b-lactamases
(ESBLs)-producing isolates, particularly among patients who
were not selected for their relationship to outbreak cases [4,5].
The aim of this study was to evaluate the prevalence of ESBL
and carbapenemase producers among intestinal microbiota of
hospitalized patients at a University hospital in Morocco. This is
the ﬁrst study of the prevalence of OXA-48 producers in this
country, where OXA-48 producers might be endemic [3].
Methods
Patients and specimens
Rectal swab specimens were randomly collected, as per survey
protocol, from 77 different hospitalized patients from any
medical unit of the University Hospital of Rabat (Morocco) in
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March 2012. Bacteria from rectal swabs were resuspended in
1 mL of sterile 0.9% saline and immediately sent at room
temperature to Bice^tre Hospital, France.
Culture screening methods
Serial dilutions of each sample (100 lL) were directly plated
on to selective media designed to identify CPE: the SUPERC-
ARBA and Brilliance CRE (OXOID, Thermo Fisher, Villebon-
sur-Yvette, France) and a screening medium designed to
identify extended-spectrum b-lactamases, ChromID ESBL
(bioMerieux, La Balme-les-Grottes, France). Moreover,
100 lL of rectal swab sample suspension were used in an
enrichment procedure consisting of an overnight culture at
37°C in 10 mL of Brain Heart Infusion broth (BHI) supple-
mented with 0.25 mg/L ertapenem (MSD, Paris, France) before
plating on to the SUPERCARBA medium. Plates were
incubated for 18 h at 37°C. Quantiﬁcation was performed by
counting the growing colonies and estimating the number of
CFU/g of stools. Estimation of the amount of stools harboured
by a swab was c. 100 mg.
Detection and identiﬁcation of CPE- and ESBL-producing
Enterobacteriaceae
Presumptive Enterobacteriaceae were identiﬁed according to
the colour of the colonies on the chromogenic media (Brilliance
CRE and ChromID ESBL). On SUPERCARBA, lactose-positive
and oxidase-negative colonies were retained for further
analysis. Presumptive CPE and ESBL-producing Enterobacteri-
aceae were identiﬁed by the Api 20E system (bioMerieux) and
susceptibility testing was evaluated by disk diffusion according
to the CLSI guidelines [6]. Non-fermenting Gram negatives
growing as white or naturally pigmented colonies on ChromID
ESBL and Brilliance CRE and lactose-negative and oxi-
dase-positive colonies growing on SUPERCARBA have been
excluded, as well as Enterococci and Aeromonas sp., growing as
blue colonies on ChromID ESBL and Brilliance CRE. Minimum
inhibitory concentrations (MICs) of imipenem, ertapenem and
meropenem were determined for all Enterobacteriaceae
growing on SUPERCARBA and Brilliance CRE using Etest strips
(bioMerieux). Chromosomally-encoded AmpC hyperproduc-
tion was searched for by using cloxacillin-containing plates.
ESBL production was conﬁrmed by using the ESBLNDP test [7].
Molecular identiﬁcation of carbapenemase and ESBL genes
PCR assays and sequencing were performed with a series of
primers designed for the detection of Ambler class A (blaKPC),
B (blaVIM, blaIMP and blaNDM) and D (blaOXA-48) carbapene-
mases and ESBL genes [8].
Plasmid DNA was extracted from the stool sample swabs
using the Qiagen Plasmid DNA mini kit (Qiagen, Courtaboeuf,
France) and used as a template for PCR assays in the search for
OXA-48-producers that would not have grown on the
selective media used in this study. Plasmid DNA from
carbapenemase producers was extracted using the Kieser
technique [9] and repA PCR was performed with primers
speciﬁc to the replicase gene as originally identiﬁed from the
IncL/M-like blaOXA-48 -harbouring plasmid [10].
Multilocus sequencing typing (MLST) and Diversilab
MLST was performed for OXA-48-producing K. pneumoniae
isolates, as previously described [11]. Clonal relatedness was
established for OXA-48 producers by the use of DiversiLab, a
semi-automated typing system based on repetitive sequence-
based PCR (rep-PCR), following the manufacturer’s instruc-
tions (bioMerieux).
Sensitivity and speciﬁcity
The sensitivity and speciﬁcity were calculated for each
screening medium. True-positives were deﬁned as all pre-
sumptive CPE growing on the media and genotypically
conﬁrmed to be CPE positives. False-positives were all
presumptive Enterobacteriaceae growing on the media that
were not conﬁrmed to be CPE by PCR for the tested genes.
Non-fermenting bacteria growing on these media are fre-
quently recovered from stool samples. Speciﬁcity was then
calculated by (i) taking into account only Enterobacteriaceae
growing on those screening media and also (ii) taking into
account all the non-speciﬁcally growing bacteria (including
non-fermenting bacteria).
Results and Discussion
Prevalence and identiﬁcation of ESBL-producing
Enterobacteriaceae
Quantiﬁcation showed a much higher amount of ESBL-
producing Enterobacteriaceae, detected on the ChromID
ESBL medium, than of carbapenem-resistant bacteria, detected
on CRE/SUPERCARBA (Table 1). The occurrence of
ESBL-producing Enterobacteriaceae was high (42.8%), with
33 ESBL-positives out of 77 rectal swabs (Table 1). The
majority of ESBL-producing Enterobacteriaceae were Escheri-
chia coli (48.5%), Klebsiella pneumoniae (39.4%) and Enterobacter
cloacae (12.1%) (Table 1). CTX-M-15 and SHV-12 represented
90.9% and 9.1% of the ESBLs, respectively (Table 1).
Limited data regarding the prevalence of ESBLs in Moroccan
hospitals are available. A previous study performed in 2012 in
the same hospital, showed 28.6% of ESBL-producing Entero-
bacteriaceae in blood cultures, superﬁcial and deep pus, and
catheters [12], whereas 20.7% were recovered from October
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2006 to March 2007 in Casablanca in Enterobacteriaceae
isolated from blood cultures, urine, pus and bronchial sampling
[13]. The prevalence rate of ESBLs in rectal swabs of
hospitalized patients obtained in our study is higher than that
observed in a French hospital in 2009 (with 15.8% of
ESBL-producing strains) [14].
Sensitivity and speciﬁcity of screening media for the
detection of CPE
The prevalence of carbapenemase producers was quite high
(13%), with ten OXA-48 producers out of the 77 rectal swabs
(Table 1). Before the enrichment culture step with ertapenem,
the ChromID ESBL showed a higher sensitivity (90%) than the
Brilliance CRE and SUPERCARBA media (80%) for detection
of OXA-48. This result was due to the fact that all
OXA-48-producing isolates co-expressed an ESBL (Table 1).
Nevertheless, ChromID ESBL and Brilliance CRE showed a
lower speciﬁcity (68.6 and 86.6%, respectively) than the
SUPERCARBA (98.5%) (Table 1) for the detection of Entero-
bacteriaceae. The ChromID ESBL, Brilliance CRE and
SUPERCARBA media showed 100% sensitivity for detection
of OXA-48 producers after the enrichment step. The
enrichment procedure helped to recover two OXA-48-
producing K. pneumoniae (isolates 93 and 95, Table 1), which
were not identiﬁed by direct plating on Brilliance CRE and
SUPERCARBA media (Tables 1 and 2).
Speciﬁcity
Overall, nine non-carbapenemase-producing isolates were
detected on Brilliance CRE (false-positives), versus one on
SUPERCARBA (Table 1). All non-carbapenemase producers
growing on Brilliance CRE and SUPERCARBA were ESBL
producers (CTX-M-15 and SHV-12) or AmpC-hyperproducing
E. cloacae or C. freundii isolates, as previously reported
(Table 1) [15,16]. The sensitivity of Brilliance CRE was similar
to that previously found with reference culture strains (76.3%)
[16] and this medium allowed detection of OXA-48-producing
isolates in low-level carriage samples such as 4 9 102 CFU/g
TABLE 1. ESBL and carbapenemase-producing Enterobacteriaceae recovered from three selective media from 77 rectal swab
samples
Sample
Quantiﬁcation of
Enterobacteriaceae (CFU/g of
stools)
Occurrence of Enterobacteriaceae
after enrichment procedure
MICs (lg/mL)a
ESBL/AmpC Carbapenemase
ChromID
ESBL
Brilliance
CRE
SUPER
CARBA IPM ETP MEM
K. pneumoniae 4 >1 9 108 1 9 104 0 Yes 0.25 0.03 0.23 CTX- M-15 –
E. coli 4 >1 9 108 4 9 103 0 Yes 0.19 0.03 0.03 CTX- M-15 –
E. coli 6 >1 9 108 4 9 106 0 No 0.5 0.19 0.06 SHV-12 –
K. pneumoniae 7 2 9 102 0 0 No CTX- M-15 –
E. cloacae 8 >1 9 108 1 9 107 0 –b 0.25 0.06 0.01 AmpC –
C. freundii 8 >1 9 108 5 9 104 1 9 103 – 0.5 0.25 0.06 AmpC –
E. coli 8 >1 9 108 5 9 104 0 – 0.19 0.03 0.03 CTX- M-15 –
E. coli 9 >1 9 108 0 0 No CTX- M-15 –
E. coli 10 4 9 107 0 0 No CTX- M-15 –
K. pneumoniae 10 4 9 107 4 9 102 3 9 103 – 2 4 2 CTX- M-15 OXA-48
E. coli 15 >1 9 108 0 0 No 2 4 2 CTX- M-15 –
E. cloacae 15 1 9 106 >1 9 108 >1 9 108 – 0.75 3 0.5 CTX- M-15 OXA-48
E. coli 22 4 9 102 0 0 No 0.75 3 0.5 CTX- M-15 –
E. coli 23 2 9 102 0 0 No CTX- M-15 –
E. coli 26 5 9 107 1 9 105 0 0 No 0.19 0.03 CTX- M-15 –
E. coli 35 3 9 105 0 0 No SHV-12 –
E. coli 36 3 9 105 0 0 No CTX- M-15 –
E. coli 39 >1 9 108 1 9 108 0 No 0.38 0.19 0.06 CTX- M-15 –
E. coli 42 1 9 104 0 0 No SHV-12 –
43c 0 0 0 No – CTX- M-15 OXA-48
E. coli 47 5 9 103 0 0 No CTX- M-15 –
K. pneumoniae 48 >1 9 108 4 9 103 0 No 0.25 0.03 0.23 CTX- M-15 –
K. pneumoniae 49 7 9 106 0 0 No CTX- M-15 –
E. coli 58 4 9 107 4 9 104 0 No 0.19 0.03 0.03 CTX- M-15 –
K. pneumoniae 58 2 9 105 0 0 No CTX- M-15 –
E. cloacae 60 1 9 108 1 9 108 1 9 105 – 1 4 0.75 CTX- M-15 OXA-48
E. coli 73 4 9 103 0 0 No CTX- M-15 –
K. pneumoniae 75 3 9 102 0 0 No CTX- M-15 –
C. freundii 75 3 9 102 0 0 No AmpC –
E. coli 78 2 9 103 0 0 No CTX- M-15 –
K. pneumoniae 86 >1 9 108 >1 9 108 >1 9 108 – 2 3 1 CTX- M-15 OXA-48
K. pneumoniae 89 3 9 104 3 9 104 3 9 104 – 2 3 0.75 CTX- M-15 OXA-48
K. pneumoniae 90 7 9 107 7 9 107 7 9 107 – 2 4 2 CTX- M-15 OXA-48
E. cloacae 91 >1 9 108 >1 9 108 2 9 107 – 1 4 0.75 CTX- M-15 OXA-48
K. pneumoniae 91 >1 9 108 >1 9 108 2 9 107 – 2 4 1.5 CTX- M-15 OXA-48
K. pneumoniae 93 1 9 106 0 0 Yes 2 4 2 CTX- M-15 OXA-48
K. pneumoniae 95 0 0 0 Yes 2 4 1 CTX- M-15 OXA-48
E. cloacae 99 >1 9 108 >1 9 108 0 No 0.25 1 0.25 AmpC –
aMinimum inhibitory concentrations (MICs) of carbapenems have been determined for all samples that have grown with Brilliance CRE and SUPERCARBA.
b–, not applicable. Positive cultures after direct plating have not been used in the enrichment procedure.
cThis sample was positive by PCR on plasmid DNA extracts.
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of stools (Table 2). The presence of non-fermenting rods
(Acinetobacter baumannii or Pseudomonas aeruginosa) was rec-
ognized as non-pigmented colonies in 40/77 samples on
ChromID ESBL, 17/77 samples on Brilliance CRE, and as
lactose-negative colonies in 33/77 samples on SUPERCARBA
(Table S1, available as a supporting information ﬁle). Brilliance
CRE showed a better speciﬁcity (71.6%) than the SUPERC-
ARBA (52.2%) when the non-fermenting bacteria were
included in the calculation (Table 1). Those oxidase-positive
and/or lactose-negative rods were systematically excluded
from further analysis of this study but the growth of these
bacteria on these selective media may interfere with results of
stools that may contain low levels of CPE. Nevertheless, the
enrichment procedure helped to eliminate non-fermenting
rods that were ﬁrst detected by direct plating on SUPERC-
ARBA (11/33, Table S1).
The presence of traces of DNA, resulting from non-viable
bacteria, or of less abundant CPE in stool samples was
assessed by PCR experiments performed on plasmid DNA
extracted from the 77 rectal swabs. Only one of the
culture-negative samples contained OXA-48 DNA, most
probably from an OXA-48 producer that had not been
detected on the screening media by direct plating or after
enrichment culture with ertapenem (sample 43, Table 1). This
ADN-positive and culture-negative sample was excluded for
the determination of sensitivity and speciﬁcity of these
screening media but raises the question of true negativity for
the calculation of the detection limits.
This study showed that, in the absence of non-fermenting
rods in stools, CPE carriage of 4 9 102 CFU/g of stools could
be detected with Brilliance CRE and SUPERCARBA media (and
with ChromID ESBL for isolates co-expressing an ESBL).
A total of ten (12.8%) OXA-48-producing Enterobacteria-
ceae were recovered from 77 faecal samples, with a high
variability in the amount of faecal carriage, ranging from
4 9 102 to >1 9 108 CFU/g of stools (Table 1). These isolates
were identiﬁed as K. pneumoniae (7/10) and E. cloacae (3/10)
(Tables 1 and 3). As assessed by the result of PCR experiments,
OXA-48 was the only carbapenemase identiﬁed, whereas
NDM producers have already been isolated in Morocco [17].
The genetic relationship between the isolates was evaluated by
multilocus sequence typing and the Diversilab technique and
showed that the seven OXA-48-producing K. pneumoniae
isolates belonged to three distinct clones with only two distinct
ST types (i.e. ST 307 and ST 395) (Table 3) and the three
OXA-48-producing E. cloacae isolates were clonally related
(Table 3). As opposed to what was previously observed in this
hospital [3], the isolates identiﬁed are mainly clonally related,
but no relationship could be established between clones and
the different wards of this hospital (Table 3). All isolates were
resistant to broad-spectrum cephalosporins due to the pro-
duction of the CTX-M-15 b-lactamase, and were resistant to
ﬂuoroquinolones, trimethoprim/sulphamethoxazole, gentami-
cin, tobramycin and chloramphenicol. Most of them were also
resistant to kanamycin and tetracycline (Table 2). Plasmid
analysis identiﬁed an identical plasmid as the commonly
widespread IncL/M-like plasmid, harbouring the blaOXA-48 gene,
of c. 62-kb in size (Table 3) [10].
Conclusion
The high prevalence of faecal carriage of OXA-48-producing
Enterobacteriaceae (12.8%) among patients in this University
TABLE 2. Sensitivity and speciﬁcity of ChromID ESBL, Bril-
liance CRE and SUPERCARBA media for the detection of
OXA-48 producing Enterobacteriaceae
Screening medium
ChromID
ESBL
Brilliance
CRE SUPERCARBA
Sensitivity before enrichment (%) 90 80 80
Sensitivity after enrichment (%) 100 100 100
Speciﬁcity (%) 68.6 86.6 98.5
Speciﬁcity including the
non-fermenting bacteria (%)
29.9 71.6 52.2
TABLE 3. Genetic context of the blaOXA-48 gene and epidemiological data
Species Strain number Hospitalization unit Diversilab type/MLST Co-resistances Plasmid type
E. cloacae 15 Medicine EcA CIP, OFX, NOR, NA, C, SXT, K, TM, GM, TE IncL/M
60 Paediatrics EcA CIP, OFX, NOR, NA, C, SXT, K, TM, GM, TE IncL/M
91 Medicine EcA CIP, OFX, NOR, NA, C, SXT, K, TM, GM, TE IncL/M
K. pneumoniae 10 Cardiology Kp 1/ST307 CIP, OFX, NOR, NA, C, SXT, K, TM, GM, TE IncL/M
90 Ophtalmology Kp 1/ST307 CIP, OFX, NOR, NA, C, SXT, K, TM, GM, TE IncL/M
93 ICU Kp 1/ST307 CIP, OFX, NOR, NA, C, SXT, K, TM, GM, TE IncL/M
86 Surgery Kp 2/ST307 CIP, OFX, NOR, NA, C, SXT, TM, GM IncL/M
89 Ophtalmology Kp 2/ST307 CIP, OFX, NOR, NA, C, SXT, TM, GM IncL/M
95 Cardiology Kp 2/ST307 CIP, OFX, NOR, NA, C, SXT, TM, GM IncL/M
91 Medicine Kp 3/ST395 CIP, OFX, NOR, NA, C, SXT, K, TM, GM, TE IncL/M
CIP, ciproﬂoxacin; OFX, oﬂoxacin; NOR, norﬂoxacin; NA, nalidixic acid; C, chloramphenicol; SXT, trimethoprim-sulphametoxazole; K, kanamycin; TM, tobramycin; GM,
gentamicin; TE, tetracycline.
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Hospital in Morroco highlights the large dissemination of the
blaOXA-48 gene. This prevalence is somewhat similar to,
although lower than, that reported for NDM in Pakistan
[18]. A high prevalence of OXA-48 producers in Morocco may
in part explain their large spread in Europe [2,3,19,20]. This
study further underlines the association between CTX-M-15
and OXA-48, leading to multidrug resistance [21]. The
ertapenem enrichment procedure was useful for the detection
of two additional samples with low carriage of OXA-48
producers. Although this enrichment step is time consuming, it
could be recommended for detection of carbapenemase
producers in hospitals where OXA-48 might be endemic,
such as in North African countries.
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